377 filings
Page 12 of 19
SC 13G/A
ml90o3jzyb5n9h6
13 Feb 17
GW Pharmaceuticals PLC
12:00am
6-K
1ghuciq q7lsyy
7 Feb 17
GW Pharmaceuticals plc Reports First Quarter 2017 Financial Results and Operational
12:00am
6-K
6r98lt3t7 t5wata5hfp
9 Jan 17
Current report (foreign)
12:00am
CT ORDER
lmst77vgb
22 Dec 16
Confidential treatment order
12:00am
6-K
zx2resa
20 Dec 16
Current report (foreign)
12:00am
6-K
ehzp093 otut32mo
5 Dec 16
GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2016 Financial Results and Operational Progress
12:00am
6-K
qrjd229pf2
3 Nov 16
Current report (foreign)
12:00am
6-K
a6atohoj vh
26 Oct 16
Current report (foreign)
12:00am
6-K
vgmmggtpj8b7yenkx209
19 Oct 16
GW Pharmaceuticals plc Announces Intention to Continue Trading Exclusively on NASDAQ and Planned Cancellation of Trading of Ordinary Shares on AIM
12:00am
6-K
eb1uta
7 Oct 16
Current report (foreign)
12:00am
6-K
xrs3w
26 Sep 16
GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for Epidiolex® (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome
12:00am
6-K
pb4ir
14 Sep 16
Current report (foreign)
12:00am
6-K
dfr9aygqb1xzv3zkk5x9
9 Aug 16
GW Pharmaceuticals plc Reports Third Quarter 2016 Financial Results and Operational Progress
12:00am
6-K
bqdjys xe02rhk7pj
18 Jul 16
Current report (foreign)
12:00am
6-K
ioa3j6p7qz493 a4
14 Jul 16
Current report (foreign)
12:00am
424B5
h9iht0o4 qg8w
14 Jul 16
Prospectus supplement for primary offering
12:00am
FWP
aycsad
13 Jul 16
Free writing prospectus
12:00am
424B5
m32nu89da 67lgdkdt
12 Jul 16
Prospectus supplement for primary offering
12:00am
6-K
i4qrbv8wk429j
12 Jul 16
Current report (foreign)
12:00am